?-Casein (90-96)

?-Casein (90-96)
Product Description

Chinese peptide co provides wide range of products which includes ?-casein (90-96). It belongs toa-casein exorphins category. Contact us for more information.

Read more Show less

CPC Scientific.Inc

  • US
  • 2015
    On CPHI since
  • 500 - 999
    Employees
Company types
CMO/CDMO
Contract Service
View company profile
Categories
more categories Show less
Specifications
  • Details
    Formula: C43H64N10O12; Molecular weight: 913.04
  • Selling Points
    Brand Name; Experienced Technicians
  • Supplied from
    China
More specifications Fewer specifications
Sales Markets
Show more Show less

CPC Scientific.Inc

  • US
  • 2015
    On CPHI since
  • 500 - 999
    Employees
Company types
CMO/CDMO
Contract Service
View company profile

More Products from CPC Scientific.Inc (99)

  • ?-Amyloid BRI Protein (1-34) (reduced) 0.5mg

    Product ?-Amyloid BRI Protein (1-34) (reduced) 0.5mg

    Chinese peptide co provides wide range of products which includes ?-amyloid bri protein (1-34) (reduced) 0.5mg. It belongs to?-amyloids and related peptides category. Contact us for more information.
  • ADRM-007A

    Product ADRM-007A

    Cpc provides wide range of products which includes adrm-007a. Category: adrenomedullins. Contact us for more information.
  • ?-Amyloid Dan Protein (1-34) 0.5mg

    Product ?-Amyloid Dan Protein (1-34) 0.5mg

    Chinese peptide co provides wide range of products which includes ?-amyloid dan protein (1-34) 0.5mg. It belongs to?-amyloids and related peptides category. Contact us for more information.
  • ADRM-008A

    Product ADRM-008A

    Cpc provides wide range of products which includes adrm-008a. Category: adrenomedullins. Contact us for more information.
  • ?-Casein (90-95)

    Product ?-Casein (90-95)

    Chinese peptide co provides wide range of products which includes ?-casein (90-95). It belongs toa-casein exorphins category. Contact us for more information.
  • ADRM-009A

    Product ADRM-009A

    Cpc provides wide range of products which includes adrm-009a. Category: adrenomedullins. Contact us for more information.
  • ADRM-010A

    Product ADRM-010A

    Cpc provides wide range of products which includes adrm-010a. Category: adrenomedullins. Contact us for more information.
  • ?-Conotoxin GVIA 0.5mg

    Product ?-Conotoxin GVIA 0.5mg

    Chinese peptide co provides wide range of products which includes ?-conotoxin gvia 0.5mg. It belongs toconotoxins category. Contact us for more information.
  • ADRM-011A

    Product ADRM-011A

    Cpc provides wide range of products which includes adrm-011a. Category: adrenomedullins. Contact us for more information.
  • ?-Conotoxin GVIA 1mg

    Product ?-Conotoxin GVIA 1mg

    Chinese peptide co provides wide range of products which includes ?-conotoxin gvia 1mg. It belongs toconotoxins category. Contact us for more information.
  • ADRM-013A

    Product ADRM-013A

    Cpc provides wide range of products which includes adrm-013a. Category: adrenomedullins. Contact us for more information.
  • ?-Conotoxin MVIIC 0.5mg

    Product ?-Conotoxin MVIIC 0.5mg

    Chinese peptide co provides wide range of products which includes ?-conotoxin mviic 0.5mg. It belongs toconotoxins category. Contact us for more information.
show all 99 other products

CPC Scientific.Inc resources (1)

  • News Terlipressin Formulation with API Manufactured by CPC Scientific Approved for Further Study by the MEB

    SAN JOSE, CA., Feb 1, 2021 /CPCNewswire/ — CPC Scientific Inc. is pleased to announce that the Dutch Medicines Evaluation Board (MEB) has completed its technical review of their client’s drug product and formulation process for Terlipressin. The API provided to the client is manufactured at CPC Scientific’s GMP facility. On January 18, 2021, the MEB granted approval of the drug product and will move to the next phase to review product characterization profiles, specifications, and labels in the Netherlands. The MEB is the Dutch regulatory agency responsible for assessing, monitoring, and promoting the proper use of medicines. After final approval, the drug product will be available for sale in the Netherlands and Germany.
    15 Jun 2021